Wordt geladen...
Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
The efficacy and toxicity of oxaliplatin-based versus carboplatin/cisplatin-based doublets in patients with previously untreated nonsmall cell lung cancer (NSCLC) have been compared. We searched published randomized controlled trials of oxaliplatin-based or carboplatin/cisplatin-based medications fo...
Bewaard in:
| Gepubliceerd in: | Medicine (Baltimore) |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer Health
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4504603/ https://ncbi.nlm.nih.gov/pubmed/26166081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001072 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|